Janus Henderson SEC Filings

Janus Henderson Group director Anne Sheehan reported routine equity compensation and related tax withholding. She received a grant of 3,288 shares of Common Stock on May 11, 2026 at a reference price of $51.71 per share, representing restricted stock units that vest one year after the grant date.

On May 12, 2026, the issuer withheld 392 shares at $51.61 per share to satisfy her tax withholding obligations tied to the vesting of restricted stock units granted on May 2, 2025. After these transactions, Sheehan directly holds 16,264.982 shares of Common Stock, indicating a modest, compensation-related update rather than an open-market trade.

CASSADAY JOHN M reported acquisition or exercise transactions in this Form 4 filing.

Janus Henderson Group director John M. Cassaday reported a compensation-related share award. He received 5,899 shares of Common Stock as a grant of restricted stock units at a reference value of $51.71 per share, which vest one year after the grant date and include dividend equivalents in the form of additional restricted stock units. After this award, he directly holds 29,297 shares and indirectly holds 14,900 shares through Sundance Investments Inc., an investment trust where he is the sole shareholder.

JANUS HENDERSON GROUP PLC director Alison A. Quirk reported routine equity compensation activity in company stock. On May 11, 2026, she received a grant of 3,288 shares of Common Stock as a restricted stock unit award that vests one year after the grant date. On May 12, 2026, 417 shares were withheld by the company to cover her tax obligations related to vesting of restricted stock units that were granted on May 2, 2025, a non‑market, tax-withholding disposition. After these transactions, she directly holds 15,908 shares of Common Stock.

Janus Henderson Group director Angela Seymour Jackson reported routine equity compensation changes. On May 11, 2026, she received a grant of 3,288 shares of Common Stock as restricted stock units that vest after one year. On May 12, 2026, 1,997 shares were withheld by the issuer to cover tax obligations tied to prior RSU vesting. Following these transactions, she holds 28,786 Common Stock shares directly.

JANUS HENDERSON GROUP PLC director Leslie Seidman reported compensation-related stock transactions. On May 11, 2026, she acquired 3,288 shares of common stock as a grant of restricted stock units that vest one year after the grant date, at $51.71 per share. On May 12, 2026, 417 shares were disposed of at $51.61 per share to satisfy tax withholding obligations tied to vesting restricted stock units granted on May 2, 2025. Following these transactions, she directly holds 15,756 shares of common stock, indicating a routine equity award and associated tax withholding rather than open-market buying or selling.

Issuer submitted a Form 144 notice proposing the sale of 6,213,418 common shares. The filing lists a broker, J.P. Morgan Securities, and indicates the transaction methods include open market purchases and exercises of put/call options. Dates shown include 05/12/2026 (filing) and a transaction date of 05/15/2020.

Janus Henderson Group plc reports lower profitability for the first quarter of 2026 while progressing toward a planned sale of the company. Revenue rose to $690.0 million, up 11% year over year, driven mainly by higher average assets under management, but operating income fell to $113.9 million as expenses increased 23%, including legal, consulting and merger-related costs.

Net income attributable to JHG declined to $90.9 million, with diluted earnings per share of $0.59. Adjusted non-GAAP diluted EPS was $0.90. Assets under management were $479.6 billion, down 3% from year-end 2025, as unfavorable markets more than offset modest net sales.

The company is set to be acquired under an amended Merger Agreement by an investor group led by Trian and General Catalyst in an all-cash transaction at $52.00 per share for holders not affiliated with Trian. Shareholders have approved the deal, which is expected to close in mid-2026 subject to regulatory approvals and client consents. JHG recorded approximately $27 million of merger-related costs in the quarter and states existing cash, investments and cash flows are expected to cover liquidity needs through the anticipated closing.

Janus Henderson Group plc reported mixed first-quarter 2026 results while progressing its take-private deal. GAAP revenue was US$690.0 million, up from US$621.4 million a year earlier, with operating income of US$113.9 million versus US$153.6 million in first quarter 2025.

Adjusted operating income rose to US$170.8 million from US$156.6 million, and adjusted diluted EPS increased to US$0.90 from US$0.79, while GAAP diluted EPS declined to US$0.59 from US$0.77. Assets under management were US$479.6 billion with net sales of US$2.9 billion but negative market and FX impact. The company highlighted strong multi-year benchmark outperformance in fixed income, multi-asset and alternatives, and reiterated that its proposed acquisition by Trian and General Catalyst, overwhelmingly approved by shareholders in April, is expected to close in mid-2026 subject to customary approvals.

Soleno Therapeutics, Inc. ownership disclosure: Janus Henderson Group plc reports beneficial ownership of 1,205,303 common shares of Soleno Therapeutics, representing 2.3% of the class as of 04/30/2026.

The filing states the shares are held by multiple Janus Henderson asset managers who exercise shared voting and dispositive power on behalf of managed portfolios; the managers disclaim rights to dividends or sale proceeds.